CANLI
Yükleniyor Veriler getiriliyor…
SCI-Expanded JCR Q3 Özgün Makale Scopus
The Efficacy and Safety of Different Sericin Doses for Pleurodesis.
Archivos de Bronconeumologia 2020 Cilt 56 Sayı 4
Scopus Eşleşmesi Bulundu
3
Atıf
56
Cilt
225-233
Sayfa
Özet
Background: The aim of present study is to compare the effectiveness, side-effect potential of different doses of sericin pleurodesis. Methods: Adult, male, 12-week-old, Wistar-albino rats (n = 52), were randomly-divided into four-groups, referred to A, B, C and D. Sericin was administrated at different doses through left thoracotomy, with 15 mg sericin to Group-A, 30 mg to Group-B and 45 mg to Group-C. Group-D was assigned as control group. The rats were sacrificed 12 days later. Left-hemithorax, heart, liver and kidney were examined pathologically. Results: No foreign body reaction in the parenchyma was observed in any of the rats, while emphysema was least common in Group-B (P <.05). Multi-layer mesothelium of both pleura was most common in Group-B, while fibrosis and fibrin organization within the visceral-pleura was more successful in all of sericin treated groups than in control group (P <.05), with neither Group-A, Group-B nor Group-C being superior to each other. In the examination of collagen fibers using Masson's trichrome, “dense collagen fibers” were found in all three sericin treated groups, and differences between Groups-A, -B, -C and the control group were significant (P <.05). The probability of observing pyknotic nucleus and balloon degeneration in liver increased with increasing sericin doses (P <.05). Glomerular degeneration in kidney and the findings of pericarditis were most common in Group-C (P <.05). Conclusion: The target should be to maximize efficacy while minimizing the likelihood of side-effects. The intrapleural administration of sericin 30 mg performs better due to multi-layer mesothelial reaction being higher and emphysema being lower in Group-B, to the fewer side-effects affecting the kidney and heart, and liver toxicity not being higher.

Havuzumuzdaki Atıflar 0

Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 3.

Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi Bilgisi Otomatik ISSN Eşleştirmesi 2020 yılı verileri
Archivos de Bronconeumologia
Q3
SJR Quartile
0,302
SJR Skoru
61
H-Index
🔓
Açık Erişim
Kategoriler: Pulmonary and Respiratory Medicine (Q3)
Alanlar: Medicine
Ülke: Spain · Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR)
Bu bilgiler makale yılına göre Scimago veritabanından ISSN eşleştirmesiyle otomatik getirilmektedir. Dergi sıralama verileri Scimago'nun ilgili yılı baz alınmaktadır.

Anahtar Kelimeler

Bu makale için anahtar kelime bilgisi bulunmuyor.

Makale Bilgileri

Dergi Archivos de Bronconeumologia
ISSN 0300-2896
Yıl 2020 / 4. ay
Cilt / Sayı 56 / 4
Sayfalar 225 – 233
Makale Türü Özgün Makale
Hakemlik Hakemli
Endeks SCI-Expanded
JCR Quartile Q3
Teşvik Puanı 0,75 · YÖKSİS Akademik Teşvik
Yayın Dili İngilizce
Kapsam Uluslararası
Toplam Yazar 6 kişi
Erişim Türü Basılı
Alan Sağlık Bilimleri Temel Alanı Göğüs Cerrahisi

YÖKSİS Yazar Kaydı

Yazar Adı YAZICIOĞLU ALKIN, ŞAHİNOĞLU TUBA, UYSAL SERKAN, SUBAŞI MAHMUT, DEMİRAĞ FUNDA, YEKELER ERDAL
YÖKSİS ID 6684797

Metrikler

Scopus Atıf 3
Havuz Atıfları 0
JCR Quartile Q3
Teşvik Puanı 0,75
Yazar Sayısı 6